4148 results about "Chemical synthesis" patented technology

The present invention relates generally to the fields of oligonucleotide synthesis. More particularly, it concerns the assembly of genes and genomes of completely synthetic artificial organisms. Thus, the present invention outlines a novel approach to utilizing the results of genomic sequence information by computer directed gene synthesis based on computing on the human genome database. Specifically, the present invention contemplates and describes the chemical synthesis and resynthesis of genes defined by the genome sequence in a host vector and transfer and expression of these sequences into suitable hosts.

Chemical syntheses and medical uses of novel inhibitors of the gastric H⁺, K⁺-ATPase for the treatment and/or management of duodenal ulcers, heartburn, acid reflux, other conditions mediated by gastric acid secretion and/or psoriasis are described.

Articles comprising substantially uniform porous coatings, which may be photopatterned, are provided. The use of such porous coatings increases the surface density of attached compounds within, for example, ligand arrays prepared by methods such as regionally selective solid-phase chemical synthesis. Arrays prepared using the porous coatings may be used within a variety of diagnostic and drug discovery assays.

Methods are provided for constructing a synthetic genome, comprising generating and assembling nucleic acid cassettes comprising portions of the genome, wherein at least one of the nucleic acid cassettes is constructed from nucleic acid components that have been chemically synthesized, or from copies of the chemically synthesized nucleic acid components. In one embodiment, the entire synthetic genome is constructed from nucleic acid components that have been chemically synthesized, or from copies of the chemically synthesized nucleic acid components. Rational methods may be used to design the synthetic genome (e.g., to establish a minimal genome and/or to optimize the function of genes within a genome, such as by mutating or rearranging the order of the genes). Synthetic genomes of the invention may be introduced into vesicles (e.g., bacterial cells from which part or all of the resident genome has been removed, or synthetic vesicles) to generate synthetic cells. Synthetic genomes or synthetic cells may be used for a variety of purposes, including the generation of synthetic fuels, such as hydrogen or ethanol.

A route to the fabrication of electronic devices is provided, in which the devices consist of two crossed wires sandwiching an electrically addressable molecular species. The approach is extremely simple and inexpensive to implement, and scales from wire dimensions of several micrometers down to nanometer-scale dimensions. The device of the present invention can be used to produce crossbar switch arrays, logic devices, memory devices, and communication and signal routing devices. The present invention enables construction of molecular electronic devices on a length scale than can range from micrometers to nanometers via a straightforward and inexpensive chemical assembly procedure. The device is either partially or completely chemically assembled, and the key to the scaling is that the location of the devices on the substrate are defined once the devices have been assembled, not prior to assembly.

Modular microfluidic systems includes a plurality of microfluidic modules, each capable of performing fluidic operations including, but not limited to, filtering, splitting, regulating pressure, mixing, metering, reacting, diverting, heating, cooling, and condensing are provided. The microfluidic modules are polymeric, stencil-based structures adapted to be coupled in sequence for performing biological or chemical synthesis, including, but not limited to, chemical and biological syntheses of organic, polymer, inorganic, oligonucleotide, peptide, protein, bacteria, and enzymatic products.

A nylon powdery material used for laser sintering to quickly shape the products is prepared through chemical synthesis, surface treatment and modification. Its advantage is high sintering performance. Its products feature high strength and toughness, and low cost.

The invention describes a new calcium phosphate cement powder, whose composition can best be described over the Ca/P molar ratio range of 1.35 to 1.40, most preferably 1.39, and whose two components were prepared by wet chemical synthesis procedures. One component is chemically-synthesized, bi-phasic alpha-TCP (Ca₃(PO₄)₂, 95 wt %)+HA (Ca₁₀(PO₄)₆(OH)₂, 5 wt %) powder, while the second component is again a chemically-synthesized, single-phase DCPD (CaHPO₄·2H₂O) powder. A setting solution (Na₂HPO₄·2H₂O) is used to form a self-setting calcium phosphate cement from the powder mixture. This cement can be used as bone filler or bone substitute in applications, which require higher rates of resorption.

The invention discloses a method for synthesizing a novel amphoteric slow-breaking quick-setting asphalt emulsifier, belonging to the technical field of organic chemical synthesis. The method comprises the following steps of: reacting oleic acid with polyamine to generate acid amide polyamine, and then adding chloroactic acid to generate halogenating reaction to prepare the asphalt emulsifier, wherein the polyamine is the mixture of diethylenetriamine and triethylene tetramine. The water solubility of the hydrophilic radical of the emulsifier synthesized by the process is stronger than those of like emulsifiers, thereby obviously lowering the critical micelle concentration (CMC) value, and the particles of the produced asphalt emulsion are finer, smoother and evener. The emulsifier can effectively prevent asphalt from settling, increases the storage stability of the asphalt emulsion, reasonably regulates the charge ratio, widens the selectivity on stone materials in the application of slurry seal construction, enables the mixing time to be sufficient, and has obvious quick-setting effect and improved project quality.

The present application relates to microfluidic devices and related technologies, and to chemical processes using such devices. More specifically, the application discloses a fully automated synthesis of radioactive compounds for imaging, such as by positron emission tomography (PET), in a fast, efficient and compact manner. In particular, this application describe an automated, stand-alone, microfluidic instrument for the multi-step chemical synthesis of radiopharmaceuticals, such as probes for PET and a method of using such instruments.

The present invention belongs to the field of genomics and nucleic acid sequencing. It involves a novel method of sequencing biological material and real-time probabilistic matching of short strings of sequencing information to identify all species present in said biological material. It is related to real-time probabilistic matching of sequence information, and more particular to comparing short strings of a plurality of sequences of single molecule nucleic acids, whether amplified or unamplied, whether chemically synthesized or physically interrogated, as fast as the sequence information is generated and in parallel with continuous sequence information generation or collection.

Disclosed herein are urea-based 5-HT receptor modulators, pharmaceutically acceptable salts and prodrugs thereof, the chemical synthesis thereof, and medical use of such compounds for the treatment and/or management of 5-HT receptor-mediated disorders.

A method for the anodic electrochemical synthesis of ammonia gas. The method comprises providing an electrolyte between an anode and a cathode, providing nitrogen and hydrogen gases to the cathode, oxidizing negatively charged nitrogen-containing species and negatively charged hydrogen-containing species present in the electrolyte at the anode to form adsorbed nitrogen species and adsorbed hydrogen species, respectively, and reacting the adsorbed nitrogen species with the adsorbed hydrogen species to form ammonia. Nitrogen and hydrogen gases may be provided through a porous cathode substrate. The negatively charged nitrogen-containing species in the electrolyte may be produced by reducing nitrogen gas at the cathode and/or by supplying a nitrogen-containing salt, such as lithium nitride, into the molten salt electrolyte. Similarly, the negatively charged hydrogen-containing species in the electrolyte may be produced by reducing hydrogen gas at the cathode and/or by supplying a hydrogen-containing salt, such as lithium hydride, into the molten salt electrolyte.

A system and process for gas homogenization is disclosed. This has application in the areas of generation of gas and its conversion to electricity in downstream applications. The homogenization system minimizes variance in the gas characteristics (composition, flow, pressure, temperature), thereby rendering a steady stream of gas of consistent quality to the downstream machinery. This homogenization system can be adjusted to optimize the output gas stream for specific end-applications, or to optimize the output gas stream for different input feedstocks. This ensures that overall conversion efficiencies are maximised while keeping the process cost-effective. Such a uniform, steady output gas stream has a wide range of applications in the broad areas of generation of electricity (e.g. using internal combustion engines and combustion turbine engines), chemical synthesis (e.g. of compounds such as ethanol, methanol, hydrogen, methane, carbon monoxide, hydrocarbons), fuel-cell technologies and in polygeneration processes (processes that result in co-production of electricity and synthetic fuels).

The objective of the present invention is to confer pest resistance to plants of Poaceae without using any chemically synthesized pesticides. The pest resistance can be conferred to plants of Poaceae by isolating from a natural plant an endophytic bacterium capable of expressing pest resistance, artificially culturing the endophytic bacterium, and introducing the bacteria to a Poaceae plant of interest.

Systems and methods are disclosed for generating a proton removing agent and an acidic solution in a low voltage electrochemical system and utilizing the proton removing agent to sequester carbon dioxide from a waste gas in a carbon dioxide sequestration system and utilizing the acidic solution to catalyze at least one step of a chemical syntheses in combination with a plant based material.

This invention provides novel high density memory devices that are electrically addressable permitting effective reading and writing, that provide a high memory density (e.g., 10¹⁵ bits/cm³), that provide a high degree of fault tolerance, and that are amenable to efficient chemical synthesis and chip fabrication. The devices are intrinsically latchable, defect tolerant, and support destructive or non-destructive read cycles. In a preferred embodiment, the device comprises a fixed electrode electrically coupled to a storage medium having a multiplicity of different and distinguishable oxidation states wherein data is stored in said oxidation states by the addition or withdrawal of one or more electrons from said storage medium via the electrically coupled electrode.

A method for reducing evaporation of a liquid reagent solution during solid phase, micro-scale chemical synthesis of a molecule comprising sub-units on an open environment solid support surface. The method includes the steps of providing an open solid support surface including at least one binding site which is functionalized with a reactive chemical moiety; and depositing a substantially controlled and minute volume of liquid reagent solution onto the support surface, and in contact with the binding site. The reagent solution includes reactants contained in at least one relatively high boiling point solvent, in contrast to standard organic solvents for such reagents. Application of a high boiling point solvent substantially reduces evaporation of the reagent solution in the open environment during synthesis on the solid support while enabling the maintenance of a substantially high reaction yield.

A magnetic recording disc is provided according to the present invention for magnetic recording. The magnetic recording disc includes a disc substrate having a locking pattern etched therein. Chemically synthesized iron-platinum particles are provided in the locking pattern and completely fill the locking pattern. The chemically synthesized iron-platinum nanoparticles exhibit short-range order characteristics forming self organized magnetic arrays.

The invention discloses applications of a CRISPR/Cpf1 system in gene editing. CrRNA in the CRISPR/Cpf1 system is modified crRNA; the modification manner is desoxyribonucleic acid modification; the desoxyribonucleic acid modification method comprises the step of increasing 1-3 desoxyribonucleic acid at the 5' terminal and/or increasing 1-3 desoxyribonucleic acid at the 3' terminal of crRNA; and the desoxyribonucleic acid is deoxythymidine acid. The experiment proves that the crRNA formed through chemical synthesis and having the modification can cause the mutation of an hAAVS1 gene and a THUMPD3-AS1 gene when used for the AsCRISPR/Cpf1 system or the FnCRISPR/Cpf1 system, namely, the modified crRNA has certain gene editing capacity when used for the AsCRISPR/Cpf1 system or the FnCRISPR/Cpf1 system, and therefore, the modified crRNA has a significant application value in gene editing utilizing the CRISPR/Cpf1 system.

The present invention relates to naturally occurring and chemically synthesized small molecule antagonists of Bcl-2 family proteins. In particular, the present invention provides gossypol compounds (e.g., isomers, enantiomers, racemic compounds, metabolites, derivatives, pharmaceutically acceptable salts, in combination with acids or bases, and the like) and methods of using these compounds as antagonists of the anti-apoptotic effects of Bcl-2 family member proteins (e.g., Bcl-2, Bcl-XL, and the like). The present invention also provides compositions comprising gossypol compounds and optionally one or more additional therapeutic agents (e.g., anticancer/chemotherapeutic agents). The present invention also provides methods for treating diseases and pathologies (e.g., neoplastic diseases) comprising administering a composition comprising gossypol compounds and optionally one or more additional therapeutic agents (e.g., anticancer/chemotherapeutic agents) and/or techniques (e.g., radiation therapies, surgical interventions, and the like) to a subject or in vitro cells, tissues, and organs.

The invention discloses application of a CRISPR (clustered regularly interspaced short palindromic repeats)/Cpf1 system in gene editing. The CRISPR/Cpf1 system comprises a1), chemosynthetic crRNA or a2), a crRNA expressing carrier. The CRISPR/Cpf1 system can be c1), an LbCRISPR/Cpf1 system, c2), an Lb2CRISPR/Cpf1 system, c3), an FnCRISPR/Cpf1 system or c4), an AsCRISPR/Cpf1 system. Experiments prove that the chemosynthetic crRNA can play an effective role in guidance of Cpf1 cut-editing specific target sites, and efficiency is high. Applying the crRNA expressed by the carrier or the chemosynthetic crRNA to the CRISPR/Cpf1 system has high application value in gene editing.

The invention discloses a liquid tableware detergent composition containing natural antibacterial components. The composition is prepared by the following raw material components in percentage by weight: 10.0-30.0 percent of anionic surfactant, 1.0-10.0 percent of nonionic surfactant, 1.0-5.0 percent of ampholytic surfactant, 1.0-15.0 percent of viscosity modifier, 0.1-5.0 percent of chelate, 0.01-0.1 percent of natural antibacterial composition, 0.05-4.0 percent of other components (containing light stabilizer, antioxidant, preservative and essence) and the balance of de-ionized water. The natural antibacterial composition added in the detergent composition is one of eucalyptus oil, paeonol, rosemary and mangnolia officinalis or a mixture of several thereof, and can solve the potential problems, such as harm to consumer health, environmental pollution, adverse effect on non-target organisms and the like, of chemically synthesized antibacterial agent at the same time of keeping excellent dirt removing capacity.

The present invention relates to a fiber product having the performances of antibiosis, odor elimination, heat dissipation and cooling. The present invention comprises woven fabric, knitted fabric, non woven fabric film or a combination body of the fabric and the film, and is made by weaving continuous filament fiber or short fiber having various different cross section shapes, sizes, colors, structures, etc. The fiber adopts sub-micron or nanometer powder with high heat diffusion coefficient and low heat conduction coefficient, and is added into thermoplastic plastic grains in a quantitative way after being decentralized with an interfacial agent. The thermoplastic plastic grains are fully mixed with the sub-micron or nanometer powder with the high heat diffusion coefficient and the low heat conduction coefficient by a mixing machine or a kneading machine or by utilizing the chemical synthesis method, and then are made into masterbatch with a granulating machine, finally the fiber product having the functions of antibiosis, odor elimination, heat dissipation and cooling can be made by using the melting, and the dry and the wet spinning technologies and through the pre-designed spinneret.

Novel copper alkoxide compound based ink formulations and their chemical syntheses are disclosed. The method of using the ink formulations to print conducting copper metal lines with standard ink jet printing and curing at <150° C. is also disclosed.

The invention relates to a combination method of gasification and coke processing from inferior heavy oil, which mainly comprises the following steps of: making the heavy oil raw material in contact with a catalyst, separating product oil gas from a spent catalyst, and sending the oil gas into a subsequent separation system; sending the spent catalyst into a gasification furnace after steam stripping, separating synthetic gas obtained through gasification reaction from a half-regenerated catalyst with part of coke removed, and using the synthetic gas to produce hydrogen or as a raw material gas of C1 chemical synthesis; and sending the half-regenerated catalyst with part of coke removed to a regenerator for complete generation, and reintroducing the regenerated catalyst into a reactor. The active gasification components of the catalyst are alkali metal and alkali earth metal, the content of oxides is 2-30% by taking the total amount of the catalyst as a reference, and the atomic ratio of the alkali metal to the alkali earth metal is (0.05-1.1):1. The combination method is applicable to the production of synthetic gas or hydrogen while processing heavy oil and provides a raw material for hydrogenation process or Fisher-Tropsch synthesis.

A method and apparatus for forming a chemical hydride is described and which includes a pseudo-plasma-electrolysis reactor which is operable to receive a solution capable of forming a chemical hydride and which further includes a cathode and a movable anode, and wherein the anode is moved into and out of fluidic, ohmic electrical contact with the solution capable of forming a chemical hydride and which further, when energized produces an oxygen plasma which facilitates the formation of a chemical hydride in the solution.

An optical identification element having a synthesized chemical attached thereto includes an optical substrate having at least one diffraction grating disposed therein, the grating having a resultant refractive variation at a grating location, said grating being embedded within a substantially single material of said optical substrate; the grating providing an output optical signal indicative of a code when illuminated by an incident light signal propagating in free space, the code identifying at least one of the element and the chemical, the output signal not being a result of laser action with the grating when illuminated by said incident light signal; and the synthesized chemical being attached to the substrate.

The present invention relates to improved therapeutically active nanocomposite microstructure compositions, including nanoparticle compositions and nanoparticle preparations. Preferred embodiments include nanoparticle compositions comprising nanoparticles of a therapeutically active agent dispersed in a carrier matrix. The invention also relates to a method for preparing said compositions and preparations using solid-state mechanochemical synthesis. Further, it relates to therapeutic products produced using said compositions and to methods of treatment using the compositions.

The present invention provides methods for the chemical synthesis of nucleosides and derivatives thereof, including 2′-amino, 2′-N-phthaloyl, 2′-O-methyl, 2′-0-silyl, 2′-O-triisopropylsilyloxymethyl, 2′-OH nucleosides, C-nucleosides, nucleoside phosphoramidites, C-nucleoside phosphoramidites, and non-nucleoside derivatives.